Jaroslav Bačovský

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy

Jiří Minařík, Petr Pavlíček, Luděk Pour et al. · PLoS ONE · 2015 · 37 citations · Full text

Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice

Jiří Minařík, Tomáš Pika, Jakub Radocha et al. · BMC Cancer · 2021 · 33 citations · Full text

<scp>CD</scp>38‐negative relapse in multiple myeloma after daratumumab‐based chemotherapy

Jiří Minařík, Martin Novák, Patrik Flódr et al. · European Journal Of Haematology · 2017 · 24 citations

Comparison of imaging methods in POEMS syndrome

Jiří Minařík, Vlastimil Ščudla, Jaroslav Bačovský et al. · Biomedical Papers · 2011 · 18 citations · Full text

Prognostic Value of Hepatocyte Growth Factor, Syndecan-1, and Osteopontin in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

Jiří Minařík, Tomáš Pika, Jaroslav Bačovský et al. · The Scientific World JOURNAL · 2012 · 16 citations · Full text